Legal Representation
Attorney
M. Clare Frederick
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 2, 2020 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jun 2, 2020 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Oct 10, 2019 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Oct 10, 2019 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Oct 10, 2019 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| Sep 30, 2019 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Sep 26, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Aug 5, 2019 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 6, 2019 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Mar 6, 2019 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Mar 6, 2019 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Feb 14, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 13, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 13, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 13, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 13, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 13, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 8, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 26, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 21, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 009
Downloadable mobile application for medication tracking, scheduling, and dosage reminders for patients, caregivers, pharmacies, and any other third party
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Providing a website featuring technology that enables medication tracking, scheduling, and dosage reminders for patients, caregivers, pharmacies, and any other third party
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
MEDICATION FRIEND
Classification
International Classes
009
042